ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage

Genes & Development
R MayaM Oren

Abstract

The p53 tumor suppressor protein, a key regulator of cellular responses to genotoxic stress, is stabilized and activated after DNA damage. The rapid activation of p53 by ionizing radiation and radiomimetic agents is largely dependent on the ATM kinase. p53 is phosphorylated by ATM shortly after DNA damage, resulting in enhanced stability and activity of p53. The Mdm2 oncoprotein is a pivotal negative regulator of p53. In response to ionizing radiation and radiomimetic drugs, Mdm2 undergoes rapid ATM-dependent phosphorylation prior to p53 accumulation. This results in a decrease in its reactivity with the 2A10 monoclonal antibody. Phage display analysis identified a consensus 2A10 recognition sequence, possessing the core motif DYS. Unexpectedly, this motif appears twice within the human Mdm2 molecule, at positions corresponding to residues 258-260 and 393-395. Both putative 2A10 epitopes are highly conserved and encompass potential phosphorylation sites. Serine 395, residing within the carboxy-terminal 2A10 epitope, is the major target on Mdm2 for phosphorylation by ATM in vitro. Mutational analysis supports the conclusion that Mdm2 undergoes ATM-dependent phosphorylation on serine 395 in vivo in response to DNA damage. The dat...Continue Reading

References

Jul 27, 1990·Science·J K Scott, G P Smith
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M BalassS Fuchs
Jul 1, 1993·Genes & Development·X WuA J Levine
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Feb 7, 1998·Genes & Development·J D SilicianoM B Kastan
Oct 9, 1998·Genes & Development·A J Giaccia, M B Kastan
Oct 21, 1998·Oncogene·S Y FuchsZ Ronai
Nov 26, 1998·The Journal of Biological Chemistry·P F LambertJ N Brady
Feb 18, 1999·Molecular and Cellular Biology·M AshcroftK H Vousden
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·L Jayaraman, C Prives
Mar 11, 1999·Current Opinion in Genetics & Development·N E Sharpless, R A DePinho
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·W Tao, A J Levine
May 26, 1999·The Journal of Pathology·C Prives, P A Hall
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·W Tao, A J Levine
Nov 13, 1999·Nature Cell Biology·J D WeberD Bar-Sagi
Nov 24, 1999·European Journal of Biochemistry·C GötzM Montenarh
Dec 14, 1999·The Journal of Biological Chemistry·M Oren
Dec 23, 1999·The Journal of Biological Chemistry·S T KimM B Kastan
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·R KhosraviD Shkedy
Feb 19, 2000·Current Opinion in Genetics & Development·C J Sherr, J D Weber
Mar 9, 2000·Nature Cell Biology·M A LohrumK H Vousden
Mar 14, 2000·Molecular and Cellular Biology·J D WeberC J Sherr
Mar 18, 2000·The Journal of Biological Chemistry·S FangA M Weissman
Apr 11, 2000·Molecular and Cellular Biology·M AshcroftK H Vousden
May 10, 2000·The Journal of Biological Chemistry·T O'NeillG A Rathbun

❮ Previous
Next ❯

Citations

Jul 12, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Clare H McGowan
Jan 12, 2005·The Journal of Pathology·Philip J CoatesEric G Wright
Feb 13, 2008·Cancer Metastasis Reviews·Xiongbin LuLawrence A Donehower
Jan 15, 2009·Genetica·L P G D'ArceE T Sakamoto-Hojo
Jul 15, 2006·Journal of Molecular Histology·Midori Shimada, Makoto Nakanishi
Jan 16, 2010·Medical Oncology·Majid KheirollahiParvin Mehdipour
May 18, 2005·DNA Repair·Valerie GarciaAntony M Carr
Dec 4, 2003·Mutation Research·Clare H McGowan
Nov 13, 2002·Mutation Research·Larry H Thompson, David Schild
Oct 25, 2001·Cancer Letters·O Pluquet, P Hainaut
Nov 8, 2001·Current Opinion in Cell Biology·J Bartek, J Lukas
Dec 11, 2002·Current Opinion in Cell Biology·Olivier Stevaux, Nicholas J Dyson
Jan 16, 2002·Current Opinion in Genetics & Development·Dan Michael, Moshe Oren
May 9, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S Lain, D Lane
Sep 10, 2002·Trends in Biochemical Sciences·Lindsey D Mayo, David B Donner
Jan 1, 2003·Seminars in Cancer Biology·Dan Michael, Moshe Oren
Jan 3, 2003·Mutation Research·Jun YangPenelope J Duerksen-Hughes
May 3, 2003·Cancer Cell·Hugh Cam, Brian David Dynlacht
Jan 31, 2003·Nature·Christopher J Bakkenist, Michael B Kastan
Nov 19, 2004·Nature·Michael B Kastan, Jiri Bartek
Sep 28, 2004·Nature Cell Biology·Constantinos DemonacosNicholas B La Thangue
Jul 18, 2006·Nature Cell Biology·Jun TangXiaolu Yang
Aug 16, 2012·Nature Communications·Young Min ChungMickey C-T Hu
Jan 11, 2013·Nature Reviews. Cancer·Mark WadeGeoffrey M Wahl
Feb 27, 2007·Oncogene·H F Horn, K H Vousden
Dec 11, 2007·Oncogene·E R Phillips, P J McKinnon
Feb 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xin PanXue-Min Zhang
Feb 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiaoyong FuYi Wang
Feb 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jonathan W YoungMichael B Elowitz
Jan 8, 2011·The Journal of Biological Chemistry·Fang YuanZengqiang Yuan
Nov 18, 2010·The Journal of Biological Chemistry·David L WaningLindsey D Mayo
Apr 2, 2011·The Journal of Biological Chemistry·Brittany CrossJiandong Chen
Apr 3, 2012·The Journal of Biological Chemistry·Mu-Shui DaiHua Lu
Oct 27, 2004·The Journal of Experimental Medicine·Joanne M LumsdenRichard J Hodes
Sep 1, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Hye-Ra LeeJae U Jung
Aug 7, 2009·Molecular Biology of the Cell·Chiaw-Hwee LimYun-Jin Jiang
Oct 19, 2001·EMBO Reports·R StadA G Jochemsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.